MGFA has partnered with Bionews to feature the Myasthenia Gravis News feed on our website, providing the community with research updates, disease management insights, and relevant news. All content is original and produced by Bionews’ editorial staff, and perspectives from patients and caregivers. Information is not meant to replace or provide medical advice.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- Chronic illness forced me to reassess my approach to teaching
by Mark Harrington on August 19, 2026 at 2:00 pmFor more than 30 years, I stood in front of classrooms in two states, teaching history. I knew how to read a room and pace a lesson while making the Missouri Compromise seem worth the attention of high schoolers. Then myasthenia gravis (MG) permanently changed my schedule without permission. The stamina a classroom demands became The post Chronic illness forced me to reassess my approach to teaching appeared first on Myasthenia Gravis News.
- MG may be driven by immune cells in thymus gland going rogue
by Marisa Horak, MS on August 19, 2026 at 12:30 pmMyasthenia gravis (MG) may be driven by antibody-producing immune B-cells going rogue in the thymus gland and developing escape mechanisms that allow them to attack the body’s own healthy tissues, according to new research by U.S. scientists. “Our study suggests there’s more to myasthenia gravis than antibodies alone,” Ankit Bharat, MD, the study’s senior author The post MG may be driven by immune cells in thymus gland going rogue appeared first on Myasthenia Gravis News.
- Planning for the unpredictable: Managing MG hard days as a family
by Mark Harrington on August 19, 2026 at 11:00 amPreparing for MG flares helps families face hard days with less fear. Recognizing warning signs, prioritizing essential tasks, assembling a flare kit, and sharing responsibilities can create a safer, more resilient household. The post Planning for the unpredictable: Managing MG hard days as a family appeared first on Myasthenia Gravis News.
- Disease Course and Variability in Myasthenia Gravis
by Margaret Rockwood on August 18, 2026 at 12:56 pmWhat to expect when managing individuals with MG, from early-onset symptoms and fluctuations to stabilization. The post Disease Course and Variability in Myasthenia Gravis appeared first on Myasthenia Gravis News.
- Treatment cuts exacerbation, rescue therapy risk in generalized MG
by Andrea Lobo on August 18, 2026 at 12:00 pmUplizna (inebilizumab) reduced the frequency of disease exacerbations, or periods when symptoms worsen, and the need for rescue therapy in people with generalized myasthenia gravis (gMG). That’s according to a prespecified analysis of data from the global Phase 3 MINT clinical trial (NCT04524273), which showed that after six months of treatment, the risk of an The post Treatment cuts exacerbation, rescue therapy risk in generalized MG appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.
